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ABSTRACT
Despite the increasing knowledge about DNA methy-
lation, the understanding of human epigenome evo-
lution is in its infancy. Using whole genome bisulfite
sequencing we identified hundreds of differentially
methylated regions (DMRs) in humans compared to
non-human primates and estimated that ∼25% of
these regions were detectable throughout several
human tissues. Human DMRs were enriched for spe-
cific histone modifications and the majority were lo-
cated distal to transcription start sites, highlighting
the importance of regions outside the direct regula-
tory context. We also found a significant excess of
endogenous retrovirus elements in human-specific
hypomethylated.
We reported for the first time a close interplay be-
tween inter-species genetic and epigenetic variation
in regions of incomplete lineage sorting, transcrip-
tion factor binding sites and human differentially hy-
permethylated regions. Specifically, we observed an
excess of human-specific substitutions in transcrip-
tion factor binding sites located within human DMRs,
suggesting that alteration of regulatory motifs un-
derlies some human-specific methylation patterns.
We also found that the acquisition of DNA hyperme-
thylation in the human lineage is frequently coupled
with a rapid evolution at nucleotide level in the neigh-
borhood of these CpG sites. Taken together, our re-
sults reveal new insights into the mechanistic basis
of human-specific DNA methylation patterns and the
interpretation of inter-species non-coding variation.
INTRODUCTION
A major aim of molecular biology is to understand the
mechanisms that drive specific phenotypes. Humans and
great apes differ in numerous morphological and cognitive
aspects. However, their coding sequences are highly simi-
lar and most of the differences are located in non-coding
regions (1), making it a challenge to define clear genotype-
phenotype associations. It has been proposed that human
specific traits originate from gene regulatory differences
rather than from changes in the primary genetic sequence
(2). The characterization of regulatory domains is therefore
a promising strategy to unveil regions of relevance for hu-
man evolution and to understand the implications of non-
coding variation.
DNA methylation is a key regulatory mechanism of the
genome (3). It is present in many taxa and, in mammals,
it plays an essential role in numerous biological processes
ranging from cell differentiation to susceptibility to com-
plex diseases (4,5). From a mechanistic perspective, DNA
methylation has been described as an intermediate regula-
tory event,mediating the effect of genetic variability on phe-
notype formation (6). However, the mechanisms by which
the DNAmethylation profile is generated are poorly under-
stood.DNAmethylation function is highly dependent on its
location. In promoters, for example, it tends to confer gene
repression while in gene bodies it is associated with tran-
scriptional activation (3,7). DNA methylation levels also
depend on the underlying genetic sequence and the occu-
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pancy of DNA binding factors (8,9). There is therefore no
generic rule that can be applied to all biological situations,
indicating the high complexity of theDNAmethylation reg-
ulatory network.
In recent years, due to the development of genome-wide
techniques that allow us to analyze DNA methylation pro-
files in multiple organisms, the field of comparative epige-
nomics has started to emerge. Exciting questions about
howDNAmethylation patterns vary through time and how
this variation is linked to genome evolution can now be
addressed. It has been shown that the global pattern of
DNA methylation between close species, such as human
and chimpanzee, is similar (10). Nonetheless, there is a spe-
cial interest in the study of local changes as mechanisms of
species evolution, specially of human evolution (11). Pre-
vious studies have identified several differentially methy-
lated regions between human and primates using differ-
ent techniques (12–19). Interestingly, many of these regions
have been associated not only with tissue-specific functions,
but also with developmental and neurological mechanisms
(13,15,19). A key question that arises is how the epigenetic
variability is generated and transmitted across generations.
The best studied mechanism is the dependence of DNA
methylation levels on the genetic sequence. A growing num-
ber of studies in humans have shown an association be-
tween a nucleotide variant and a state of methylation (6,20).
However the relationship between the genetic and the epi-
genetic sequence has not been explored when studying dif-
ferent species and despite recent advances in the field, many
unanswered questions remain: How do DNA methylation
patterns diverge across different genomic features? What
are the processes driving such differences? Is this epigenetic
variation associated with a higher rate of nucleotide substi-
tution?
To further investigate these questions, we determined
blood DNA methylation patterns in human, chimpanzee,
gorilla and orangutan samples using whole genome bisul-
fite sequencing. Because this technique is not dependent on
predefined sequences or methylation-dependent restriction
enzymes, it is superior to other assays in analyzing patterns
of DNA methylation (10,12,13). We identified hundreds of
human regions that differ in the DNA methylation pattern
compared to the rest of great apes. These regions were en-
riched for specific histone modifications and they were lo-
cated distal to transcription start sites. Furthermore, we
found that DNA methylation variation and the underlying
genetic code show close physical dependencies.
MATERIALS AND METHODS
The bisulfite sequencing data discussed in this publication
have been deposited to the NCBI SRA database under the
accession number SRP059313.
Sample collection
Human and non-human research has been approved by the
ethical committee of the European Research Union. Hu-
man donors gave written informed consent to take part
in the study. We obtained methylation data from periph-
eral whole blood DNA extracted from a human, a chim-
panzee, a gorilla and an orangutan sample (Supplemen-
tary Table S1). Furthermore we obtainedDNAmethylation
data from a human CD19+ sample. All samples were ob-
tained from healthy donors and DNA was extracted using
phenol:chloroform:isoamylalcohol (Sigma). CD19+ sam-
ple was separated using the CD19+ cell Isolation kit II
(Miltenyi Biotec) following the manufacturer’s instructions.
DNA methylation data from additional samples (CD4+
and solid tissues) were obtained from previous publica-
tions, (21) and (GSE46698), respectively. Monocyte and
neutrophil data were retrieved from Blueprint portal (http:
//dcc.blueprint-epigenome.eu/#/md/data).
Library preparation
We spiked genomic DNA (1 or 2 g) with unmethylated 
DNA (5 ng of DNA per g of genomic DNA) (Promega).
We shearedDNAby sonication to 50–500 bpwith aCovaris
E220 and selected 150–300 bp fragments using AMPure
XP beads (Agencourt Bioscience Corp.). We constructed
genomic DNA libraries using the TruSeq Sample Prepara-
tion kit (Illumina Inc.) following Illumina’s standard pro-
tocol. After adaptor ligation, we treated DNA with sodium
bisulfite using the EpiTect Bisulfite kit (Qiagen) follow-
ing the manufacturer’s instructions for formalin-fixed and
paraffin-embedded (FFPE) tissue samples. We performed
two rounds of conversion to achieve >99% conversion.
We enriched adaptor-ligated DNA through seven cycles of
polymerase chain reaction (PCR) using the PfuTurboCx
Hotstart DNA polymerase (Stratagene). We monitored li-
brary quality using the Agilent 2100 BioAnalyzer (Agi-
lent) and determined the concentration of viable sequencing
fragments (molecules carrying adapters at both extremities)
by quantitative PCR using the Library Quantification Kit
from KAPA Biosystems. We performed paired-end DNA
sequencing (two reads of 100 bp each) using the Illumina
Hi-Seq 2000. Sequencing quality was assessed using the Il-
lumina Sequencing Analysis Viewer and FastQC software.
We ensured the raw reads used in subsequent analyses were
within the standard parameters set by the Illumina proto-
col. Positional quality along the reads was confirmed to be
QC>30, and we excluded biases toward specific motifs or
GC-enriched regions in the PCRamplification or hybridiza-
tion.
Mapping and annotation
Paired-end sequencing reads (100 bp) were mapped to
the in silico bisulfite–converted human (hg19), chimpanzee
(panTro4) (1), gorilla (gorGor3) (22) and orangutan (pon-
Abe2) (23) references genomes using Bismark v0.7.8 (24)
not allowing multiple alignments. We also removed poten-
tial PCR duplicates using Bismark’s deduplicate bismark
program. Custom Perl scripts were used to summarize the
methylation levels of individual cytosines based on fre-
quency of mapped reads.
To facilitate an unbiased comparison of the four genomes
we used the Enredo-Pecan-Orthus (EPO) whole-genome
multiple alignments of human, chimpanzee, gorilla and
orangutan [Ensemble Compara.6 primates EPO] (25). We
identified 8,952,000 CpG positions shared among the four
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species in autosomal chromosomes, this data set was used
for further analysis.
Global methylome analysis
We used 5,946,947 CpG sites presenting a read coverage be-
tween 4X and 30X in all species to perform global methy-
lome comparisons according to their genomic annotation.
Promoter regions were defined as±2 kb interval of the tran-
scription start site. CpG island and repeat families were an-
notated using human UCSC Genome Browser tracks (26).
We used incomplete lineage sorting (ILS) coordinates pre-
viously described (22). To assess significance of the ILS
clustering a permutation test was performed as follows:
based on the number of CpG sites in ILS regions, [221 908
for ((CG), H)) regions and 142,231 for ((HG)C))], we ran-
domly sampled from the total set of shared CpG sites across
species (5,946,947 CpG sites) and determined the species
clustering. This process was repeated 10,000 times to cre-
ate the null distribution. The P-value corresponded to the
number of times the ILS clustering appeared within the
null distribution divided by the number of permutations (n
= 10,000). We also calculated the number of CpG sites in
which the absolute methylation difference between the clos-
est species (CG or HG) was smaller than between compar-
isons with the third species and then compared it to the null
distribution.
Identification of differentially methylated regions
Methylation values and number of reads in each position
were used to identify hypomethylated regions (HMRs) us-
ing each reference genome coordinates by using a two-
state HiddenMarkov model (15). The algorithm was devel-
oped to assess the methylation profile in humans and chim-
panzees by dividing the methylome into regions of hyper-
methylation and hypomethylation. Non-human HMRs co-
ordinates were converted hg19 coordinates using the EPO
alignments. To call hypomethylated DMRs we first inter-
sected a speciesHMRswith the other threemethylomes and
performed inter-species comparisons. To call hypermethy-
lated DMRs, we intersected three species HMRs and then
compared the methylation patterns to the methylome of the
species of interest.
In order to define a species-specific differentially methy-
lated region (DMR), we required a stringent threshold of>
0.3 in mean CpGmethylation difference and a minimum of
5 CpGs (coverage between 4X and 30X) in all species. On
the one hand, we observed no differences between genome-
wide and DMR read coverage distribution (Supplementary
Figure S1). On the other hand, since methylation values
can be interpreted as the percentage of CpG methylation
at a given site, a difference of 0.3 in CpG methylation in-
dicates that there has been a change of methylation in 30%
of the molecules tested. The proportion of cells present in
the blood, being predominately neutrophils and lympho-
cytes, has comparable proportions in chimpanzee, gorilla
and orangutan (27,28) (Supplementary Table S2), being the
highest differences between human and gorilla neutrophils
(20%). Therefore, as our DMR analysis required a mean
CpG methylation difference > 0.3, changes in blood cell
fractions have unlikely affected our results.
Pyrosequencing
Specific sets of primers for PCR amplification and sequenc-
ing were designed using a specific software pack (Pyro-
Mark assay design version 2.0.01.15). PCR was performed
under standard conditions with biotinylated primers and
the PyroMark Vacuum Prep Tool (Biotage, Sweden) was
used to prepare single-stranded PCR products according
to manufacturer’s instructions. Pyrosequencing reactions
and methylation quantification were performed in a Pyro-
Mark Q96 System version 2.0.6 (Qiagen) using appropriate
reagents and recommended protocols.
Genomic divergence and TFBS
We computed lineage specific nucleotide substitutions by
extracting EPO multi-alignments blocks of human DMRs
and flanking regions. Flanking regions were chosen with
length equal to DMRs and located from 1 to 5 kb upstream
and downstream of DMRs. We then calculated the number
of lineage specific nucleotides and divided by the amount of
nucleotides present in the four species. Insertions and dele-
tions were not taken into account in this analysis. Transcrip-
tion factor binding sites coordinates were previously identi-
fied (29) and human specific substitutions were also calcu-
lated using EPO multi-alignments blocks.
Histone modification enrichment
The genomic distribution shown in Figure 4A, was per-
formed considering the human hg19 RefGene annotation
using PAVIS (30). We used processed ChIP-seq data previ-
ously published (31). To determine enrichment and signifi-
cance of a particularmodification, we generated 100 control
sets sized-matched of the human hypo- and hypermethy-
latedDMRs independently. To generate this control data set
we also took into account chromosome location, CpG den-
sity and length. Next, we determined the proportion of each
histone codification overlapping the human DMRs and the
control data sets. The ratio of the two is reported as enrich-
ment shown in Figure 4D. The P-value corresponded to the
number of times that the DMRs proportions appeared in
control data set distribution, divided by the number of sets
(n= 100). Similarly, to determine the significance of DMRs
location we calculated the proportion of DMRs ± 30 kb
around TSS (RefSeq genes) and compared to the control
data set distribution. TheP-value corresponded to the num-
ber of times that the DMRs proportion appeared in control
data set distribution, divided by the number of sets (n =
100).
RESULTS
We performed whole genome bisulfite sequencing of whole
blood derivedDNA from a human (Homo sapiens), a chim-
panzee (Pan troglodytes), a western gorilla (Gorilla gorilla)
and a Sumatran orangutan (Pongo abelii) individual. A
total of ∼ 1.6 billion 100 bp Illumina paired-end reads
were uniquely aligned to their respective reference genomes
(hg19, panTro4 (1), gorGor3 (22), ponAbe2 (23)) using Bis-
mark (24). To facilitate an unbiased comparison between
the four species, we performed all inter-species comparisons
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based on 6-primate EPO (25) restricting our analysis to 8
952 000 CpG sites conserved between the four species (see
Materials and Methods). Compared to previous studies,
this approach allowed us to reliably analyze a greater pro-
portion of the species epigenomes. The read coverage in this
subset of CpG sites averaged 10X in human, 12X in chim-
panzee, 12X in gorilla and 13X in orangutan (Supplemen-
tary Figure S2).
A global view of great Ape methylomes
Overall, the four species exhibited similar levels of DNA
methylation with average levels of 74% in human, 71%
in chimpanzee, 71% gorilla and 70% in orangutan sam-
ples (Figure 1A). These findings are comparable to levels
reported in previous studies analyzing blood methylomes
(21,32). To investigate the epigenetic divergence between
species, we retained 5,946,947 CpG sites that had between
4X and 30X coverage in all species and performed correla-
tion analysis in different regions of the genome. Here, the
correlation coefficients of DNA methylation levels between
species were in agreement with species phylogeny, the high-
est being in human-chimpanzee comparisons and the lowest
in all comparisons involving orangutan (Figure 1B). From
a genomic perspective, DNA methylation values correlated
notably in promoters andCpG island regions and to a lesser
extent at repeat loci (Figure 1B). Among the major repeat
families,Alu elements presented the lowest correlation coef-
ficients between species (Figure 1B). Only high confidence
reads mapping uniquely to orthologous regions were con-
sidered, wherein no major differences in coverage were ob-
served (Supplementary Figures S3 and S4). However, due
to the exclusion of multi-mapping read information and
the high frequency of C>T mutations resulting from CpG
deamination in repetitive elements, further studies are re-
quired to confirm the significance of these findings.
To gain insights into the relationship between nucleotide
sequence and DNA methylation levels, we analyzed the
DNA methylation patterns of regions whose sequence ge-
nealogy differs from the species phylogeny, known as re-
gions of incomplete lineage sorting (ILS) (22). Specifically,
we studied regions where humans are more closely related
to gorillas than to chimpanzees, represented as ((H,G)C)O)
and regions where chimpanzees are more closely related to
gorillas than to humans, represented as ((C,G)H)O). These
regions are typically small (average length 473 bp) and con-
tained 364,139 CpG sites conserved among all four species
(Supplementary Figure S5). Interestingly, hierarchical clus-
tering and correlation analyses showed incomplete lineage
sorting also at DNA methylation levels (Figure 1C) (P <
0.0001). Furthermore we estimated that 25% and 33% of
CpG sites within ((C,G)H)O) and ((H,G)C)O) regions re-
spectively, are in concordance with the ILS pattern (P <
0.0001). These results suggest a physical interplay between
the methylation levels of a substantial fraction of CpG sites
and the genetic sequence. While environmental heterogene-
ity can contribute to epigenetic variation (33) and there-
fore, it is a common confounding factor when comparing
epigenomes of different species, the study of ILS regions al-
lowed us to overcome this limitation. In addition, although
80% of the analyzed regions are not located either at pro-
moters or within coding sequences, it has been shown that
nearby genes present higher expression divergence between
human and chimpanzee (22).
Species-specific DNA methylation patterns
We then focused our study on species-specific regions, which
present a DNA methylation pattern exclusive to a single
species. Therefore, we first identified hypomethylated re-
gions (HMRs) throughout the genomes using a Hidden
MarkovModel (15). This algorithm has been previously ap-
plied on human and chimpanzee DNA methylomes to de-
tect putative regulatory regions (15,34,35). We identified 28
835 (34.9 Mb) HMRs in human, 29 257 (33.6 Mb) in chim-
panzee, 30 782 (36.5 Mb) in gorilla and 27 349 (33.1 Mb)
regions in orangutan DNAmethylomes. These hypomethy-
lated regions were similar in size and methylation levels in
all species (Supplementary Figure S6) and harbored ∼15%
of the CpG sites tested. Interestingly, an average of 72%
(24.9Mb) ofHMRswere shared among all species andwere
mostly located in or close to human CpG islands (42.6% in
CpG islands and 52.6% in CpG shores).
The resulting hypomethylated blocks were used to per-
formDNAmethylation inter-species comparisons (see Ma-
terials andMethods). Due to the epigenomic differences be-
tween blood cell types (36), we required a stringent thresh-
old of > 0.3 in mean CpG methylation difference (at least
30% methylation difference) to define a species-specific dif-
ferentially methylated region (DMR) (see Materials and
Methods). Moreover, this threshold allowed us to iden-
tify potential variant regions with higher biological impact.
We defined two categories of DMRs: hypomethylated re-
gions (in which one species is uniquely hypomethylated)
(Supplementary Table S3) and hypermethylated regions (in
which one species is uniquely hypermethylated) (Supple-
mentary Table S4). Overall, we identified 360 hypomethy-
lated DMRs in human (1.2% of HMRs), 340 in chim-
panzee (1.1% of HMRs), 845 in gorilla (2.7% of HMRs)
and 1015 in orangutans (4.2% of HMRs) (Figure 2A). Fur-
ther, we determined 210 DMRs specifically hypermethy-
lated in human, 124 in chimpanzee, 167 in gorilla and 698 in
orangutans (Figure 2A). One limitation of themethodwhen
calling a species hypermethylated DMRs is the intersection
of multiple HMRs (from the other species) what resulted
in smaller and fewer hypermethylated DMRs. Interestingly,
species-specific hypomethylated regions were smaller in size
(Wilcoxon test; P < 0.01) and had lower CpG density
(Wilcoxon test; P < 0.01) compared to HMRs common to
the analyzed species. Due to the methodological limitations
when calling hypermethylated DMRs, we could not assess
size differences in this data set.
Importantly, we validated the results in an independent
cohort of 48 individuals (31 humans, 5 chimpanzees, 6 goril-
las and 6 orangutans), confirming differential DNAmethy-
lation in 88% (14/16) of randomly selected human DMRs,
underlining the reliability of the genome-wide screening ap-
proach (Supplementary Figure S7). An interesting exam-
ple is represented by an intergentic regions (Figure 2B)
specifically hypomethylated in human whole blood com-
pared to chimpanzee, gorilla and orangutan. Interestingly,
we also observed hypomethylation at this region when com-
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Figure 1. Global DNAmethylation patterns. (A) DNA methylation profile of 5 946 947 CpG sites shared among the four species. (B) Pairwise-correlation
analysis in different regions of the genome (right). Genome-wide n = 5 946 947, promoter n = 1 466 948, CpG Island n = 740 153, repeats n = 2 310 842,
LINE n= 433 317, LTR n= 385 009, SINE 141 380, Alu 1 160 930, other n= 190 206. Density scatterplot of DNAmethylation levels between human and
chimpanzee genome-wide and in Alu elements (left), R indicates the Pearson correlation coefficient. (C) Hierarchical cluster tree and pairwise-correlation
analysis based of methylation data from incomplete lineage sorting regions. O(G(C,H) n = 922 701, O(H(C,G)) n = 221 908, O(C(H,G)) n = 142 231.
paring with published human methylomes (lymphoid (21)
and myeloid cell types, and three other solid tissue types:
brain, placenta and liver (37)]), indicating that this pattern
is independent of cell types and likely to be conserved dur-
ing development. Additional information (31) suggests that
this region acts as strong enhancer (lymphocyte and lung
fibroblast), weak enhancer (mammary epithelial cells) and
weak promoter (myoblasts, umbilical vein endothelial cells,
embryonic stem cells and keratinocytes). An illustrative ex-
ample of a human specific hypermethylated DMR which is
conserved across both human hematopoietic cell types and
solid tissues, is represented by the last exon and 3′ UTR of
the SEMA6C gene (Figure 2C). This gene encodes a mem-
ber of the semaphorin family involved in axonal growth
and synaptic connectivity maintenance (38). This regions
is annotated as weakly transcribed region (lymphocyte, my-
oblast, lung fribroblast and umbilical vein endothelial cells,)
and as inactive promoter (mammary epithelial cells, embry-
onic stem cells and keratinocytes)(31). Overall, we deter-
mined a strong correlation in the DNA methylation pro-
file of human DMRs between the human whole blood sam-
ple and major hematopoietic cell types (Pearson’s correla-
tion test, r2 > 0.8; Figure 2D). Herein, 66% of human hy-
pomethylated DMRs and 64% of human hypermethylated
DMRs were also detectable in the sorted blood cell types
(mean difference < 0.3 between human whole blood and
all cell types). In addition, 20% and 36% of human hypo-
and hypermethylated DMRs, respectively, were detectable
in all human tissues including solid cell types (brain, pla-
centa, liver) (Figure 2D).
Genomic divergence in differentially methylated regions
We further investigated the relationship between epigenetic
and genetic evolution. First, we evaluated evolutionary con-
servation within human DMRs and flanking regions us-
ing the PhastCons score (Cons 46-Way) from all species
(vertebrate) and two subsets (primate and placental mam-
mal) (39,40). Interestingly, human hypo- and hypermethy-
lated DMRs are more evolutionary conserved than the
flanking regions (Supplementary Figure S8 and Figure 3).
The conservation in deep phylogenies suggests that these
regions may have important biological functions. Second,
we aimed to determine the association between changes in
DNA methylation and changes in the underlying genetic
sequence. Therefore, we used the EPO multi-alignments
blocks (25) to calculate lineage specific nucleotide substitu-
tions that occurred in human DMRs and at their flanking
regions (see Materials and Methods). We observed that hu-
man hypermethylated DMRs accumulated nucleotide sub-
stitutions in the same branch where the DNA methylation
change occurred, clearly suggesting the epigenetic evolu-
tion to be coupled with nucleotide changes in these regions
(Wilcoxon test, P < 0.05; Figure 3A). Moreover, due to
the fact that hypermethylated cytosines deaminate sponta-
neously, we hypothesized a decrease in the number of CpG
sites in the hypermethylated species as result of C>T mu-
tations. However, no significant differences in CpG density
were observed between species (Figure 3B) and no increase
at C>Tmutation was observed when classifying the human
specific substitutions (Figure 3C), demonstrating that the
increase of nucleotide substitutions is not due to cytosine
deamination. Surprisingly, we instead observed an increase
in the frequency of C>G mutations within human hyper-
methylated DMRs. Previous studies has pointed to oxida-
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Figure 2. Differentially methylated regions. (A) Heat maps showing species specific hypo- (top) and hypermethylated (bottom) DRMs. Each vertical line
represents the mean methylation value of a region. (B) Browser representation of human hypomethylated DMR (C) human hypermethylated DMR, within
SEMA6C. Each vertical bar shows the methylation value of a single CpG site. Black blocks correspond to hypomethylated regions (HMRs) called by the
HiddenMarkovModel algorithm.Human samples:WB (whole blood), monocyte and neutrophil (myeloid lineage), CD19+ andCD4+ (lymphoid lineage),
liver, brain and placenta. Non-human samples: WB: whole blood. The bottom panel displays the chromatin-state segmentation track (ChromHMM) for 7
different cell types (B-lymphocyte, lung fibroblast, HMEC: mammary epithelial cells, skeletal muscle myoblasts, HUVEC: umbilical vein endothelial cells,
hESC: embryonic stem cells, epidermal keratinocytes). (D) Pearson correlation matrix of human hypo- and hypermethylated DMRs.
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Figure 3. Nucleotide divergence at human hypermethylated DMRs. (A) Top, nucleotide changes of human hypermethylated DMRs estimated in each
species lineage. The color plot represents the methylation state of the lineage species, red hypermethylated and blue hypomethylated. Data are represented
as mean ± 2 standard deviations above and below the mean. Bottom, PhastCons score (Cons 46-Way) from all species (vertebrate) and two subsets
(primate and placental mammal). (B) Number of CpG sites per kb in human hypermethylated DMRs estimated at each species lineage. (C) Classification
of human-specific substitutions showing an excess of C>G mutations at human hypermethylated DMRs compared to the flanking regions.
tive conditions as the cause of this type of mutation (41),
however further studies are required to interpret our find-
ing.
In contrast to the association of the genetic and epige-
netic code in hypermethylated DMRs, human specific hy-
pomethylated DMRs did not show significant differences in
the rate of nucleotide substitutions compared to their flank-
ing regions (Supplementary Figure S8), suggesting that al-
ternative mechanisms are implicated in the evolutionary
loss of CpG methylation.
Functional context of human DMRs
To further investigate the mechanistic links between genetic
and epigenetic changes we studied the DNA sequence of a
high-confidence set of predicted transcription factor bind-
ing sites (TFBS) located within human-specific DMRs in-
ferred using the CENTIPEDEalgorithm (29).We first iden-
tified 699 and 274 TFBS overlapping with hypo- and hy-
permethylated DMRs respectively, and compared these to
752 143 TFBS present in the 5 946 947 CpG sites data set
(background). We then identified the proportion of bind-
ing sites whose DNA sequence is conserved between species
and the proportion of binding sites containing at least
one human specific change (Figure 4A). Within human-
specific DMRs we observed a significant increase in the fre-
quency of human-specific substitutions in predicted TFBS
when compared with TFBS in the background set (P <
0.001 hypomethylated DMRs and P = 0.008 hypermethy-
lated DMRs; Supplementary Figure S9), indicating a close
evolutionary relationship between predicted TFBS and lo-
cal DNA methylation patterns. However, it is of note that
TFBS in hypermethyldated DMRs can be affected by the
overall increased nucleotide substitution rate in these re-
gions.
We also examined the presence of common repetitive
elements within human-specific DMRs. Interestingly, we
found that 399 CpG sites located at human hypomethylated
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Figure 4. Characteristics of human DMRs. (A) Increase of human-specific substitutions in TFBS within DMRs compared with TFBS in the background
set. Conserved binding sites (gray) and binding sites with human-specific changes (orange). (B) Fraction of CpG sites overlapping with ERV elements (C)
Distribution of human hypo- and hypermethylated DMRs. (D) Histone modification enrichment at human hypo- and hyper DMRs. Active promoter:
H3K9ac, enhancer: H3K4me1, repressive promoter: H3K27me3, gene body: H3K36me3 and heterochromatin: H3K9me3 **denotes P < 0.001 and *
denotes P < 0.01 (permutation test).
DMRs, representing 12% of all CpG sites located within hy-
pomethylated human DMRs, overlapped with endogenous
retroviruses (ERVs) (Figure 4B). This represents a two-fold
enrichment over the background (P < 0.001; Supplemen-
tary Figure S10). Recent studies indicate that ERV ele-
ments participate in transcriptional regulation duringmam-
malian development (42). Hence, our results suggest that
ERV methylation levels could also be an important driving
force in shaping primate epigenomes.
In total, 13.6% and 21.0% of hypo- and hypermethy-
lated human DMRs, respectively, overlapped with pro-
moter or exonic regions (Figure 4C). To investigate the
functional role of the human DMRs, we determined their
co-localization with histone mark occupancy data derived
from chromatin immunoprecipitation sequencing (ChIP-
seq) experiments in whole blood (31). Specifically, we in-
tegrated DMRs with histone modifications data marking
promoter, enhancer, gene body and heterochromatic re-
gions (H3K9ac, H3K4me1, H3K27me3, H3K36me3 and
H3K9me3). Here, we found that 52% of hypomethylated
DMRs and 50% of hypermethylated DMRs co-localize
with at least one histone modification. To determine a sig-
nificant enrichment of a particular modification, we gen-
erated a set of random DMRs taking into account size,
length, chromosomal location and CpG density. We ob-
served that hypomethylatedDMRs overlapped significantly
with the regulatory histone marks H3K9ac, H3K27me3
and H3K4me1, regions with putative functions in devel-
opmental processes (43), whereas hypermethylated DMRs
were significantly enriched at loci marked by H3K27me3
(Permutation test P < 0.01; Figure 4D). In addition, we
found that human DMRs were located distal to transcrip-
tion start sites (TSS) compared to the distribution of the
random DMRs (Supplementary Figure S11). In particu-
lar, 44% and 37% of hypo- and hypermethylated DMRs,
respectively, were located > 30 kb away from the closest
TSS (random DMRs: mean hypo = 17%, mean hyper =
28%) (Permutation test P < 0.01 and P = 0.01, respec-
tively). We therefore conclude that human DMRs are sig-
nificantly enriched in regions occupied by active histone
marks and are located outside the proximal gene regula-
tory context. Previous studies have shown that tissue reg-
ulatory events are mainly mediated by distal enhancers
(32,44). Here, we propose enhancer and bivalent regions
(H3K4me1 and H3K27me3) not only to be involved in the
determination of cellular phenotypes, but also species phe-
notypes. However, further studies comparing DNA methy-
lation maps from different tissues are required to under-
stand tissue-specificity from an evolutionary point of view.
DISCUSSION
The current study provides one of the first genome-wide
comparison of genetic and epigenetic variation among hu-
mans and our closest living relatives. Previous studies have
analyzed a limited proportion of the genome using ar-
ray methods or methylation-dependent restriction enzymes
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(6,10,12,13,17,18). Moreover the here applied use of EPO-
alignments allowed us to cover a greater proportion of the
epigenome in comparison to studies restricted to ortholo-
gous genes (14).
We found an overall conservation of the DNA methy-
lation profiles between species. In concordance with previ-
ous studies (13,45,46), our results showed high conservation
of DNA methylation levels specifically at CpG islands and
gene promoters. Nevertheless, we found 570 regions that
presented an exclusive pattern of DNA methylation in hu-
mans and contrary to expectation, these tend to be located
distally to transcription start sites. This fact has to be taken
into account in future evolutionary research, as to datemost
studies focused on the role of promoter DNA methylation
and gene silencing. In this context, it was described that
differences in promoter methylation underlie only 12–18%
of differences in gene expression levels between humans
and chimpanzees (12). However, in our genome-wide study
we have observed that most human-specific changes occur
outside gene promoters. Because distal regulatory elements
may contribute to transcriptional activity we hypothesize
that the proportion of differences in expression levels ex-
plained byDNAmethylationmay be higher when analyzing
whole-genome data sets. In this sense, this epigenetic varia-
tion could underlie tissue differences between species. Nev-
ertheless, we have shown that 20% and 36% of human hypo-
and hypermethylated DMRs, respectively, were detectable
throughout several human tissues, suggesting their conser-
vation during development. This phenomenon could also
explain the discrepancy between certain DMRs and tissue
function (for example, DMRs associated to neuronal genes
detected in blood; Figure 2C) and highlights the importance
of developmental and cell differentiation processes in the
generation of species-specific traits.
Inter-species DNA methylation divergence can be a con-
sequence of genetic differences between species but also a
consequence of sequence-independent mechanisms, such as
environmental factors or stochastic events. In non-model
organisms these effects are often difficult to exclude and
therefore, the observed DNA methylation differences be-
tween species may be a consequence of environmental fac-
tors on that lineage. In order to homogenize the different
environments, all non-human samples in this studywere ob-
tained from zoos. However as additional external factors
are challenging to control for (e.g. the intake of cooked food
in humans), we cannot finally exclude that different environ-
ments have partially confounded the results. Importantly,
we have replicated the results in larger cohorts of donors
from all species and shown a close physical relationship be-
tween the genetic and the epigenetic code in three differ-
ent analyses. Firstly, we have shown ILS of DNA methy-
lation levels in regions that do not follow the species tree,
suggesting a dependence of DNA methylation state on the
underlying genetic sequence. Secondly, we have determined
that a substantial and significant proportion of transcrip-
tion factor binding sites at human DMRs contain human-
specificmutations. This suggests amechanistic link between
the modification of binding sites at the nucleotide level and
alterations ofDNAmethylation (47). Thirdly, we found that
the acquisition of DNA hypermethylation in the human
lineage is frequently coupled with a rapid evolution at nu-
cleotide level in the neighborhood of these CpG sites. This
would initially suggest a loss of functionality of these re-
gions and the subsequent accumulation of mutations. How-
ever, the observation of an enrichment for specific histone
modification contradicts this hypothesis and rather point to
a complex regulatory mechanism between histone modifi-
cations, DNA methylation and the underlying genetic se-
quence. The relationship between the species genetic back-
ground and the epigenetic code identified here also indicates
that in most of these regions DNAmethylation changes are
not generated by stochastic events, environmental factors
or cell type composition. The genetic-epigenetic association
also suggests that DNA methylation patterns at these re-
gions are a fixed feature in the human epigenome and ex-
cludes potential bias due to our limited sample sized. How-
ever, further studies are needed to accurately determine the
exact genetic origin of the inter-species epigenetic variation.
This will probably require larger sample sizes, the combina-
tion of individual genetic and epigenetic data sets and direct
experimentation.
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Supplementary Data are available at NAR Online.
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